查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831791

低分子CDMO市场，规模，占有率，趋势，产业分析报告:各医药品类型，各产品，各用途，各地区-2025年～2034年的市场预测

Small Molecule CDMO Market Size, Share, Trend, Industry Analysis Report By Drug Type (Innovators, Generics), By Product, By Application, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2034年，小分子CDMO市场规模将达到1,336.3亿美元。该报告深入分析了当前的市场动态，并分析了未来的市场成长。

小分子CDMO市场涵盖专注于小分子化合物的合约开发和生产服务，为製药和生物技术公司从早期开发到商业化生产的整个过程提供支援。该市场由日益增长的合约生产需求所驱动，旨在降低成本、加快进度，并获得製剂、製程开发和法规遵循的专业知识。肿瘤学、罕见疾病和中枢神经系统治疗的发展增加了计画的复杂性，促使人们更加依赖CDMO来获得客製化解决方案和灵活的能力。专利到期正在扩大仿製药的研发管线，为建立具有成本效益的生产合作伙伴关係创造了机会。产业趋势包括采用连续生产、绿色化学实践和先进的分析能力，以提高效率并满足严格的品质标准。药物开发商和CDMO之间的策略联盟日益普遍，从而实现风险共担并加速创新。

对药物生命週期内可扩展解决方案的需求日益增长，加上製程优化和自动化方面的进步，为供应商创造了巨大的机会，使其能够透过技术深度和监管专业知识实现差异化。对上市速度的日益重视，尤其是对于小众和罕见疾病药物而言，进一步加强了能够提供敏捷合规生产的专业CDMO的作用。竞争格局有利于那些投资于技术整合、扩展服务组合併建立稳固的长期合作伙伴关係以满足不断变化的治疗和生产需求的参与者。

小分子CDMO市场报告重点

按产品类型划分，由于越来越多的复杂合成工艺外包给专业的CDMO，活性药物成分细分市场在2024年占了市场主导地位。

按药物类型划分，由于新型小分子疗法的外包量较大，创新药物领域在 2024 年占了最大的收入占有率。

由于拥有先进的製药生产基础设施、完善的监管框架以及大型药物开发公司的高外包需求，北美在 2024 年占了小分子 CDMO 市场的主导地位。

由于製药生产能力的扩大、对先进生产设备的投资增加以及对具有成本效益的外包解决方案的需求不断增长，预计亚太市场将在 2025 年至 2034 年间实现最高的复合年增长率。

小分子 CDMO 市场的全球参与者包括 Aurigene Pharmaceutical Services Ltd.；Bellen Chemistry；Cambrex Corporation；Catalent, Inc.；CordenPharma International；Eurofins Scientific；Lonza；Recipharm AB；Siegfried Holding AG；和赛默飞世尔 目录公司

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球低分子CDMO市场洞察

  • 市场概述
  • 低分子CDMO市场动态
    • 促进因素和机会
      • 仿製药生产规模扩大
      • 新兴治疗领域的研发活动不断增加
    • 限制因素与挑战
      • 严格的监管要求和品质合规标准增加了营运复杂性
  • PESTEL分析
  • 小分子 CDMO 市场趋势
  • 价值链分析

第5章 全球低分子CDMO市场:各产品

  • 主要调查结果
  • 简介
  • 医药品有效成分(API)
  • 完成医药品

第6章 全球低分子CDMO市场:各医药品类型

  • 主要调查结果
  • 简介
  • 创新者
  • 学名药
  • 手册

第7章 全球低分子CDMO市场:各用途

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 心血管疾病
  • 中枢神经系统(CNS)的疾病
  • 自体免疫/发炎
  • 其他

第8章 全球低分子CDMO市场:各地区

  • 主要调查结果
  • 简介
    • 低分子CDMO市场分析:地区，2020～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各医药品类型，2020～2034年
    • 北美:各用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各医药品类型，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各医药品类型，2020～2034年
    • 亚太地区:各用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各医药品类型，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2020-2034年
    • 南美:各医药品类型，2020～2034年
    • 南美:各用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Aurigene Pharmaceutical Services Ltd.
  • Bellen Chemistry
  • Cambrex Corporation
  • Catalent, Inc.
  • CordenPharma International
  • Eurofins Scientific
  • Lonza
  • Recipharm AB
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
Product Code: PM6332

The small molecule CDMO market size is expected to reach USD 133.63 billion by 2034, according to a new study by Polaris Market Research. The report "Small Molecule CDMO Market Size, Share, Trend, Industry Analysis Report By Drug Type (Innovators, Generics), By Product, By Application, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The small molecule CDMO market encompasses contract development and manufacturing services focused on low molecular weight drug compounds, supporting pharmaceutical and biotechnology companies from early-stage development through commercial production. The market is driven by increasing demand for outsourced manufacturing to reduce costs, accelerate timelines, and access specialized expertise in formulation, process development, and regulatory compliance. Growth in oncology, rare diseases, and central nervous system therapies is increasing project complexity, prompting greater reliance on CDMOs for tailored solutions and flexible capacity. Patent expirations are expanding the generic drug pipeline, generating opportunities for cost-effective production partnerships. Industry trends include the adoption of continuous manufacturing, green chemistry practices, and advanced analytical capabilities to enhance efficiency and meet stringent quality standards. Strategic collaborations between drug developers and CDMOs are becoming more prevalent, enabling shared risk and accelerated innovation.

The rising need for scalable solutions across the drug lifecycle, combined with advancements in process optimization and automation, creates significant opportunities for providers to differentiate through technical depth and regulatory expertise. Growing emphasis on speed-to-market, particularly for niche and orphan drugs, is further strengthening the role of specialized CDMOs that can deliver agile and compliant manufacturing. The competitive environment favors players who invest in technology integration, expand service portfolios, and build strong, long-term partnerships to address evolving therapeutic and manufacturing demands.

Small Molecule CDMO Market Report Highlights

By product, the active pharmaceutical ingredient segment dominated the market in 2024 driven by the increasing outsourcing of complex synthesis processes to specialized CDMOs.

Based on drug type, the innovators segment held the largest revenue share in 2024 due to the high level of outsourced manufacturing for novel small molecule therapies.

North America dominated the small molecule CDMO market in 2024 due to a strong presence of advanced pharmaceutical manufacturing infrastructure, well-established regulatory frameworks, and high demand for outsourcing from large-scale drug developers.

The market in Asia Pacific is expected to register the highest CAGR from 2025 to 2034 due to expanding pharmaceutical manufacturing capacity, increasing investments in advanced production facilities, and rising demand for cost-effective outsourcing solutions.

A few global key players in the small molecule CDMO market include Aurigene Pharmaceutical Services Ltd.; Bellen Chemistry; Cambrex Corporation; Catalent, Inc.; CordenPharma International; Eurofins Scientific; Lonza; Recipharm AB; Siegfried Holding AG; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the market report on the basis of product, drug type, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Active Pharmaceutical Ingredients (API)

Finished Drug Products

By Drug Type Outlook (Revenue, USD Billion, 2020-2034)

Innovators

Generics

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiovascular Disease

Central Nervous System (CNS) Conditions

Autoimmune/Inflammation

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Small Molecule CDMO Market Insights

  • 4.1. Small Molecule CDMO Market - Market Snapshot
  • 4.2. Small Molecule CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expansion of Generic Drug Production
      • 4.2.1.2. Rising R&D Activities in Emerging Therapeutic Areas
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory requirements and quality compliance standards increase operational complexity
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Small Molecule CDMO Market Trends
  • 4.6. Value Chain Analysis

5. Global Small Molecule CDMO Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Active Pharmaceutical Ingredients (API)
    • 5.3.1. Global Small Molecule CDMO Market, by Active Pharmaceutical Ingredients (API), by Region, 2020-2034 (USD Billion)
  • 5.4. Finished Drug Products
    • 5.4.1. Global Small Molecule CDMO Market, by Finished Drug Products, by Region, 2020-2034 (USD Billion)

6. Global Small Molecule CDMO Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • 6.3. Innovators
    • 6.3.1. Global Small Molecule CDMO Market, by Innovators, by Region, 2020-2034 (USD Billion)
  • 6.4. Generics
    • 6.4.1. Global Small Molecule CDMO Market, by Generics, by Region, 2020-2034 (USD Billion)
  • 6.5. Manual
    • 6.5.1. Global Small Molecule CDMO Market, by Manual, by Region, 2020-2034 (USD Billion)

7. Global Small Molecule CDMO Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Small Molecule CDMO Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Cardiovascular Disease
    • 7.4.1. Global Small Molecule CDMO Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Billion)
  • 7.5. Central Nervous System (CNS) Conditions
    • 7.5.1. Global Small Molecule CDMO Market, by Central Nervous System (CNS) Conditions, by Region, 2020-2034 (USD Billion)
  • 7.6. Autoimmune/Inflammation
    • 7.6.1. Global Small Molecule CDMO Market, by Autoimmune/Inflammation, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Small Molecule CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Small Molecule CDMO Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Small Molecule CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Small Molecule CDMO Market - North America
    • 8.3.1. North America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.3.4. Small Molecule CDMO Market - U.S.
      • 8.3.4.1. U.S.: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.3.5. Small Molecule CDMO Market - Canada
      • 8.3.5.1. Canada: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.4. Small Molecule CDMO Market - Europe
    • 8.4.1. Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.4. Small Molecule CDMO Market - UK
      • 8.4.4.1. UK: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.5. Small Molecule CDMO Market - France
      • 8.4.5.1. France: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.6. Small Molecule CDMO Market - Germany
      • 8.4.6.1. Germany: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.7. Small Molecule CDMO Market - Italy
      • 8.4.7.1. Italy: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.8. Small Molecule CDMO Market - Spain
      • 8.4.8.1. Spain: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.9. Small Molecule CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.10. Small Molecule CDMO Market - Russia
      • 8.4.10.1. Russia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.11. Small Molecule CDMO Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.5. Small Molecule CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.4. Small Molecule CDMO Market - China
      • 8.5.4.1. China: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.5. Small Molecule CDMO Market - India
      • 8.5.5.1. India: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.6. Small Molecule CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.7. Small Molecule CDMO Market - Japan
      • 8.5.7.1. Japan: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.8. Small Molecule CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.9. Small Molecule CDMO Market - South Korea
      • 8.5.9.1. South Korea: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.10. Small Molecule CDMO Market - Australia
      • 8.5.10.1. Australia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.11. Small Molecule CDMO Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.6. Small Molecule CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.4. Small Molecule CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.5. Small Molecule CDMO Market - UAE
      • 8.6.5.1. UAE: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.6. Small Molecule CDMO Market - Israel
      • 8.6.6.1. Israel: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.7. Small Molecule CDMO Market - South Africa
      • 8.6.7.1. South Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.8. Small Molecule CDMO Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.7. Small Molecule CDMO Market - Latin America
    • 8.7.1. Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.4. Small Molecule CDMO Market - Mexico
      • 8.7.4.1. Mexico: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.5. Small Molecule CDMO Market - Brazil
      • 8.7.5.1. Brazil: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.6. Small Molecule CDMO Market - Argentina
      • 8.7.6.1. Argentina: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.7. Small Molecule CDMO Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Aurigene Pharmaceutical Services Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bellen Chemistry
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cambrex Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Catalent, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CordenPharma International
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eurofins Scientific
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lonza
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Recipharm AB
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Siegfried Holding AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 3 Global Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 6 North America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 7 U.S.: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 9 U.S.: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Canada: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 12 Canada: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 15 Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 16 UK: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 18 UK: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 19 France: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 21 France: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Germany: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 24 Germany: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Italy: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 27 Italy: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Spain: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Russia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 36 Russia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 43 China: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 45 China: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 46 India: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 48 India: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Japan: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 54 Japan: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 58 South Korea: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 60 South Korea: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Australia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 63 Australia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 73 UAE: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 75 UAE: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Israel: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 78 Israel: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 79 South Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 81 South Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 87 Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Mexico: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 90 Mexico: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Brazil: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 93 Brazil: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 94 Argentina: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 96 Argentina: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Small Molecule CDMO Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Small Molecule CDMO Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Small Molecule CDMO Market, by Drug Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Small Molecule CDMO Market, by Application, 2024 & 2034 (USD Billion)